Patterson Matthew R 4
4 · Audentes Therapeutics, Inc. · Filed Jan 10, 2020
Insider Transaction Report
Form 4
Patterson Matthew R
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2020-01-08$9.50/sh+11,824$112,328→ 249,792 total - Exercise/Conversion
Common Stock
2020-01-08$15.26/sh+11,666$178,023→ 261,458 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-08−74,297→ 0 totalExercise: $2.19Exp: 2025-02-04→ Common Stock (74,297 underlying) - Gift
Common Stock
2019-12-26−12,500→ 98,920 total - Exercise/Conversion
Common Stock
2020-01-08$0.78/sh+64,751$50,506→ 163,671 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-08−64,751→ 0 totalExercise: $0.78Exp: 2023-09-25→ Common Stock (64,751 underlying) - Exercise/Conversion
Common Stock
2020-01-08$2.19/sh+74,297$162,710→ 237,968 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-08−11,824→ 143,569 totalExercise: $9.50Exp: 2025-12-18→ Common Stock (11,824 underlying) - Exercise/Conversion
Stock Option (right to buy)
2020-01-08−11,666→ 188,334 totalExercise: $15.26Exp: 2027-01-25→ Common Stock (11,666 underlying)
Holdings
- 171,814(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The reporting person is the trustee of the Matthew R. Patterson Revocable Trust.
- [F2]The option vested as to 25% of the total shares on January 1, 2014, and then 6.25% of the total shares quarterly thereafter, with 100% of the total shares vested and exercisable on January 1, 2017.
- [F3]The option vested as to 25% of the total shares on February 4, 2016, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on February 4, 2019.
- [F4]The option vested as to 6.25% of the total shares quarterly, beginning March 18, 2016, with 100% of the total shares vested and exercisable on December 18, 2019.
- [F5]The option vests as to 2.0833% of the total shares monthly, beginning February 25, 2017, with 100% of the total shares vested and exercisable on January 25, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.